DE68907909T2 - Präparat zur behandlung von erektionsstörungen. - Google Patents

Präparat zur behandlung von erektionsstörungen.

Info

Publication number
DE68907909T2
DE68907909T2 DE89909891T DE68907909T DE68907909T2 DE 68907909 T2 DE68907909 T2 DE 68907909T2 DE 89909891 T DE89909891 T DE 89909891T DE 68907909 T DE68907909 T DE 68907909T DE 68907909 T2 DE68907909 T2 DE 68907909T2
Authority
DE
Germany
Prior art keywords
erectional
disorders
treating
preparation
treating erectional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89909891T
Other languages
English (en)
Other versions
DE68907909D1 (de
DE68907909T3 (de
Inventor
Nils Kock
Gerhard Lycke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amsu Ltd
Original Assignee
Amsu Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20373202&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68907909(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amsu Ltd filed Critical Amsu Ltd
Publication of DE68907909D1 publication Critical patent/DE68907909D1/de
Application granted granted Critical
Publication of DE68907909T2 publication Critical patent/DE68907909T2/de
Publication of DE68907909T3 publication Critical patent/DE68907909T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE68907909T 1988-09-02 1989-09-01 Präparat zur behandlung von erektionsstörungen. Expired - Lifetime DE68907909T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8803087A SE463851B (sv) 1988-09-02 1988-09-02 Komposition foer behandling av erektil dysfunktion via uretra
SE8803087 1988-09-02
PCT/SE1989/000462 WO1990002545A1 (en) 1988-09-02 1989-09-01 Composition for the treatment of erectile dysfunction

Publications (3)

Publication Number Publication Date
DE68907909D1 DE68907909D1 (de) 1993-09-02
DE68907909T2 true DE68907909T2 (de) 1993-12-23
DE68907909T3 DE68907909T3 (de) 2004-02-26

Family

ID=20373202

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68907909T Expired - Lifetime DE68907909T3 (de) 1988-09-02 1989-09-01 Präparat zur behandlung von erektionsstörungen.

Country Status (16)

Country Link
US (4) US5849803A (de)
EP (2) EP0357581B2 (de)
JP (1) JPH0791199B2 (de)
AU (1) AU638414B2 (de)
CA (1) CA1335346C (de)
DE (1) DE68907909T3 (de)
DK (1) DK175560B1 (de)
ES (1) ES2055677T5 (de)
FI (1) FI102454B1 (de)
GR (1) GR900300093T1 (de)
IE (1) IE62587B1 (de)
NO (1) NO301046B1 (de)
NZ (1) NZ230400A (de)
SE (1) SE463851B (de)
WO (1) WO1990002545A1 (de)
ZA (1) ZA896681B (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
DK0526566T3 (da) * 1990-04-25 1999-08-09 Vivus Inc Behandling af erektil dysfunktion
US5962528A (en) * 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
US5981593A (en) * 1991-07-03 1999-11-09 Scott; Nathan Earl Prostaglandin E2 treatment of impotence
WO1993000894A1 (en) * 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
US6291528B1 (en) 1991-07-03 2001-09-18 Nathan Earl Scott Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
US20030181355A1 (en) * 1992-05-29 2003-09-25 Glenn Jeffrey S. Method for inhibition of viral infection
US5503973A (en) * 1992-05-29 1996-04-02 The Regents Of The University Of California Method for inhibition of viral morphogenesis
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
CA2215307A1 (en) * 1995-03-14 1996-09-19 Vivus, Incorporated Pharmaceutical compositions and kits for preventing erectile dysfunction
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
GB9608408D0 (en) * 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
IT1292377B1 (it) 1997-06-19 1999-02-08 Nicox Sa Composizioni farmaceutiche a base di prostaglandine
IT1292426B1 (it) 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
JP2001509480A (ja) 1997-07-09 2001-07-24 アンドロソリューションズ，インク． 男性勃起機能不全を治療するための改良された方法及び組成物
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US6200288B1 (en) 1997-08-26 2001-03-13 Queen's University At Kingston Everting toroid device for insertion into a body cavity
US5954688A (en) * 1997-08-26 1999-09-21 Queen's University At Kingston Everting toroid device for delivering a drug into a body cavity
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
CA2314369A1 (en) * 1997-12-18 1999-06-24 Nathan Earl Scott Prostaglandin e2/f2.alpha. combination for treating impotence and enhancing sexual arousal
EP1062508A1 (de) 1998-03-20 2000-12-27 The Rockefeller University Screeningtests für verbindungen welche mit kationenkanälen interagieren, mutierte prokaryonte kationenkanal-proteine und deren verwendung
US6194433B1 (en) 1998-10-05 2001-02-27 Neal R. Cutler Sexual dysfunction in females
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6110489A (en) * 1998-05-01 2000-08-29 Cutler; Neal R. Use of quinolines and quinolones to treat male erectile dysfunction
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6132757A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6132753A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
US6365590B1 (en) 1998-05-26 2002-04-02 Saint Louis University Compounds, compositions and methods for treating erectile dysfunction
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6482426B1 (en) 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
WO2000032195A1 (fr) * 1998-12-02 2000-06-08 Mochida Pharmaceutical Co., Ltd. Preparations destinees a etre administrees par voie uretrale
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US7176238B1 (en) 1999-03-01 2007-02-13 Nitromed Inc. Nitrostated and nitrosylated prostaglandins, compositions and methods of use
US6613768B1 (en) 1999-04-30 2003-09-02 Lilly Icos Llc Treatment of female arousal disorder
US7893021B2 (en) * 1999-06-02 2011-02-22 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
AUPQ105799A0 (en) 1999-06-18 1999-07-08 Victor Chang Cardiac Research Institute, The Cell growth inhibition
US6303135B1 (en) 1999-07-08 2001-10-16 Neal R. Cutler Use of quinolines and quinolones to treat male erectile dysfunction
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
WO2002007757A2 (en) 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
EP1404336A1 (de) * 2001-06-14 2004-04-07 Sampad Bhattacharya Zusammensetzungen enthaltend cgmp-pde5-hemmar zur transdermalen verabreichung zur erektilgewebe des penises
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
CN1203055C (zh) 2001-09-26 2005-05-25 朱德煦 治疗或预防细菌感染的方法和组合物
US7041677B2 (en) 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
AU2003220173A1 (en) * 2002-03-08 2003-09-22 Abgent, Inc. Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof
US7919098B2 (en) 2002-03-26 2011-04-05 Zensun ( Shanghai ) Sci & Tech Co., Ltd. ErbB-3 based methods and compositions for treating neoplasms
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
KR20040043996A (ko) * 2002-11-20 2004-05-27 조나겐, 아이엔씨. 남성 발기부전치료를 위한 개선된 조성물
US7196093B2 (en) * 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7868011B2 (en) * 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
CN1869002A (zh) * 2005-05-27 2006-11-29 中国科学院上海药物研究所 一类非甾体雄激素受体调节剂、其制备方法和用途
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US8889635B2 (en) 2008-09-30 2014-11-18 The Regents Of The University Of Michigan Dendrimer conjugates
WO2010054321A2 (en) 2008-11-07 2010-05-14 The Regents Of The University Of Michigan Methods of treating autoimmune disorders and/or inflammatory disorders
EP2488172A4 (de) 2009-10-13 2014-08-13 Univ Michigan Dendrimerzusammensetzung und verfahren zu ihrer synthese
WO2011059586A2 (en) 2009-10-30 2011-05-19 The Regents Of The University Of Michigan Multifunctional small molecules
AU2010355614B2 (en) 2010-06-13 2015-07-02 Institute Of Biophysics, Chinese Academy Of Sciences Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
WO2013085718A1 (en) 2011-12-08 2013-06-13 The Regents Of The University Of Michigan Multifunctional small molecules
US11339371B2 (en) 2012-07-23 2022-05-24 Institute Of Biophysics, Chinese Academy Of Sciences Method for inducing pluripotent stem cells to differentiate into ventricular myocytes in vitro
CN109276705B (zh) 2012-10-08 2023-10-20 上海泽生科技开发股份有限公司 治疗糖尿病患者心力衰竭的组份和方法
JP6568052B2 (ja) 2013-05-22 2019-09-04 ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． 心不全を治療するためのニューレグリンの徐放
CN113289002A (zh) 2020-02-24 2021-08-24 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
FR2509175B1 (fr) * 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
EP0149254A3 (de) * 1983-12-29 1987-01-28 The Research Foundation Of State University Of New York Fungizide Mittel Polypeptide mit L-Histidin enthaltend
DE3637157A1 (de) * 1985-11-01 1987-05-21 Byk Gulden Lomberg Chem Fab Arzneimittel zur behandlung erektiler dysfunktionen
EP0266968A3 (de) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelierte Salbe mit einem Vasodilator
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
DE3913954A1 (de) * 1989-04-27 1990-10-31 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
US5583144A (en) * 1995-02-24 1996-12-10 Kral; John G. Methods for treating erectile impotence

Also Published As

Publication number Publication date
AU638414B2 (en) 1993-07-01
EP0357581A1 (de) 1990-03-07
EP0432199B1 (de) 1993-07-28
SE8803087L (sv) 1990-03-03
EP0432199B2 (de) 2003-07-30
FI102454B (fi) 1998-12-15
CA1335346C (en) 1995-04-25
ZA896681B (en) 1990-06-27
IE892680L (en) 1990-03-02
US5849803A (en) 1998-12-15
WO1990002545A1 (en) 1990-03-22
EP0357581B2 (de) 1998-09-16
NO301046B1 (no) 1997-09-08
US5886039A (en) 1999-03-23
NO910828L (no) 1991-04-30
FI910976A0 (fi) 1991-02-27
DK36491D0 (da) 1991-03-01
NO910828D0 (no) 1991-03-01
JPH0791199B2 (ja) 1995-10-04
ES2055677T3 (es) 1994-11-01
DE68907909D1 (de) 1993-09-02
AU4199489A (en) 1990-04-02
DE68907909T3 (de) 2004-02-26
DK36491A (da) 1991-03-01
FI102454B1 (fi) 1998-12-15
ES2055677T5 (es) 1998-11-16
IE62587B1 (en) 1995-02-08
EP0432199A1 (de) 1991-06-19
ES2055677T1 (es) 1994-09-01
JPH04501707A (ja) 1992-03-26
EP0357581B1 (de) 1993-07-28
SE463851B (sv) 1991-02-04
US5942512A (en) 1999-08-24
US5843961A (en) 1998-12-01
SE8803087D0 (sv) 1988-09-02
DK175560B1 (da) 2004-12-06
NZ230400A (en) 1992-01-29
GR900300093T1 (en) 1991-09-27

Similar Documents

Publication Publication Date Title
DE68907909T2 (de) Präparat zur behandlung von erektionsstörungen.
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE3584013D1 (de) Zubereitung zur behandlung von psoriasis.
DE3685633D1 (de) Behandlung von knochenstoerungen.
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE69019488D1 (de) Behandlung von Geflügel.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE69018043T3 (de) Behandlung von Geflügel.
NO903449D0 (no) Fremgangsmaate for aa behandle underjordiske formasjoner.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
DE3681642D1 (de) Benzopyran-verbindungen zur behandlung von inkontinenz.
DE68911776T2 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE3768459D1 (de) Duese zur zufuhr von behandlungsdraht.
DE3875016T2 (de) Therapeutikum zur behandlung von aids.
DE3751510D1 (de) Düse zur Behandlung von Fäden.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.
DE69000960D1 (de) Zusammensetzung zur behandlung von pigmentierung.
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
ATE91886T1 (de) Praeparat zur behandlung von erektionsstoerungen.
DE69000746D1 (de) Praeparat zur behandlung von systemischem lupus erythomatosus.
DE68918449T2 (de) Siliziumverbindungen zur behandlung von knochen.
DE3583337D1 (de) Zusammensetzung zur behandlung von haemorroiden.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings